SEC Filings

Filing date Description Form Filing Group View

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

An amendment to a SC 13D filing

SC 13D/A
Other
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G
Other
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

An amendment to the SC 13G filing

SC 13G/A
Other
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

424B5
Registration Statements
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.